Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Trastornos del movimiento Movement disorders 321 artículos Viendo del 1 al 40 de 321 artículos
Pub MED

Estrogen receptor activation contributes to RNF146 expression and neuroprotection in Parkinson's disease models.NUEVO

Kim H, Ham S, Lee JY, Jo A, Lee GH, Lee YS, Cho M, Shin HM, Kim D, Pletnikova O, Troncoso JC, Shin JH, Lee YI, Lee Y.
Oncotarget. 2017 Oct 11;8(63):106721-106739. doi: 10.18632/oncotarget.21828. eCollection 2017 Dec 5.
Pub MED

Neuronal activity pattern defects in the striatum in awake mouse model of Parkinson's disease.NUEVO

Chen H, Lei H, Xu Q.
Behav Brain Res. 2017 Dec 28. pii: S0166-4328(17)31519-X. doi: 10.1016/j.bbr.2017.12.018. [Epub ahead of print]
Pub MED

The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease.NUEVO

Kim K, Müller MLTM, Bohnen NI, Sarter M, Lustig C.
Neuroimage. 2017 Dec 19. pii: S1053-8119(17)31026-1. doi: 10.1016/j.neuroimage.2017.12.012. [Epub ahead of print]
Pub MED

Factors influencing psychological well-being in patients with Parkinson's disease.NUEVO

Nicoletti A, Mostile G, Stocchi F, Abbruzzese G, Ceravolo R, Cortelli P, D'Amelio M, De Pandis MF, Fabbrini G, Pacchetti C, Pezzoli G, Tessitore A, Canesi M, Zappia M.
PLoS One. 2017 Dec 15;12(12):e0189682. doi: 10.1371/journal.pone.0189682. eCollection 2017.
Pub MED

Ginsenoside Rb1 confers neuroprotection via promotion of glutamate transporters in a mouse model of Parkinson's disease.NUEVO

Zhang YL, Liu Y, Kang XP, Dou CY, Zhuo RG, Huang SQ, Peng L, Wen L.
Neuropharmacology. 2017 Dec 12;131:223-237. doi: 10.1016/j.neuropharm.2017.12.012. [Epub ahead of print]
Pub MED

[When germs get involved in Parkinson's disease].NUEVO

Khenniche Y, Lutete E, Bobé P.
Med Sci (Paris). 2017 Nov;33(11):950-953. doi: 10.1051/medsci/20173311011. Epub 2017 Dec 4. French. No abstract available.
Pub MED

Pilot study: molecular risk factors for diagnosing sporadic Parkinson's disease based on gene expression in blood in MPTP-induced rhesus monkeys.NUEVO

Shi L, Huang C, Luo Q, Xia Y, Liu H, Li L, Liu W, Ma W, Fang J, Tang L, Zeng W, Chen Z.
Oncotarget. 2017 Nov 10;8(62):105606-105614. doi: 10.18632/oncotarget.22348. eCollection 2017 Dec 1.
Pub MED

Age-Dependence and Aging-Dependence: Neuronal Loss and Lifespan in a C. elegans Model of Parkinson's Disease.NUEVO

Apfeld J, Fontana W.
Biology (Basel). 2017 Dec 23;7(1). pii: E1. doi: 10.3390/biology7010001.
Pub MED

Diminished EEG habituation to novel events effectively classifies Parkinson's patients.NUEVO

Cavanagh JF, Kumar P, Mueller AA, Richardson SP, Mueen A.
Clin Neurophysiol. 2017 Dec 13;129(2):409-418. doi: 10.1016/j.clinph.2017.11.023. [Epub ahead of print]
Pub MED

Being on target: visual information during writing affects effective connectivity in Parkinson's disease.NUEVO

Nackaerts E, Michely J, Heremans E, Swinnen S, Smits-Engelsman B, Vandenberghe W, Grefkes C, Nieuwboer A.
Neuroscience. 2017 Dec 30. pii: S0306-4522(17)30917-X. doi: 10.1016/j.neuroscience.2017.12.027. [Epub ahead of print]
Pub MED

Increased pulsatility index supports diagnosis of vascular parkinsonism versus idiopathic Parkinson's disease.NUEVO

Caba LM, Ferrairó JIT, Torres IM, Costa JFV, Muñoz RB, Martin AL.
Neurologia. 2017 Dec 29. pii: S0213-4853(17)30353-5. doi: 10.1016/j.nrl.2017.10.008. [Epub ahead of print] English, Spanish.
Pub MED

Neuroprotective effect of olfactory ensheathing cells co-transfected with Nurr1 and Ngn2 in both in vitro and in vivo models of Parkinson's disease.NUEVO

Liu Q, Qin Q, Sun H, Zhong D, An R, Tian Y, Chen H, Jin J, Wang H, Li G.
Life Sci. 2017 Dec 29. pii: S0024-3205(17)30688-4. doi: 10.1016/j.lfs.2017.12.038. [Epub ahead of print]
Pub MED

DLG2, but not TMEM229B, GPNMB, and ITGA8 polymorphism, is associated with Parkinson's disease in a Taiwanese population.NUEVO

Wu HC, Chen CM, Chen YC, Fung HC, Chang KH, Wu YR.
Neurobiol Aging. 2017 Dec 8. pii: S0197-4580(17)30387-1. doi: 10.1016/j.neurobiolaging.2017.11.016. [Epub ahead of print]
Pub MED

Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease.NUEVO

Sekar S, Taghibiglou C.
Neurosci Lett. 2017 Dec 26;666:139-143. doi: 10.1016/j.neulet.2017.12.049. [Epub ahead of print]
Pub MED

Tamoxifen and the Risk of Parkinson's Disease in Female Patients with Breast Cancer in Asian People: A Nationwide Population-Based Study.NUEVO

Hong CT, Chan L, Hu CJ, Lin CM, Hsu CY, Lin MC.
J Breast Cancer. 2017 Dec;20(4):356-360. doi: 10.4048/jbc.2017.20.4.356. Epub 2017 Dec 19.
Pub MED

Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.NUEVO

Harrison IF, Smith AD, Dexter DT.
Neurosci Lett. 2017 Dec 19;666:48-57. doi: 10.1016/j.neulet.2017.12.037. [Epub ahead of print]
Pub MED

Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease.NUEVO

Silva de Lima AL, Hahn T, Evers LJW, de Vries NM, Cohen E, Afek M, Bataille L, Daeschler M, Claes K, Boroojerdi B, Terricabras D, Little MA, Baldus H, Bloem BR, Faber MJ.
PLoS One. 2017 Dec 20;12(12):e0189161. doi: 10.1371/journal.pone.0189161. eCollection 2017.
Pub MED

Processing of implicit versus explicit predictive contextual information in Parkinson's disease.NUEVO

Li L, Diaz-Brage P, Fernandez-Lago H, Fogelson N.
Neuropsychologia. 2017 Dec 5;109:39-51. doi: 10.1016/j.neuropsychologia.2017.12.006. [Epub ahead of print]
Pub MED

Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.NUEVO

Li XR, Ren YD, Cao B, Huang XL.
Neurosci Lett. 2017 Nov 30. pii: S0304-3940(17)30973-4. doi: 10.1016/j.neulet.2017.11.064. [Epub ahead of print]
Pub MED

Effects of Exercise on Non-Motor Symptoms in Parkinson's Disease.NUEVO

Amara AW, Memon AA.
Clin Ther. 2017 Nov 30. pii: S0149-2918(17)31066-4. doi: 10.1016/j.clinthera.2017.11.004. [Epub ahead of print]
Pub MED

Repositioning drugs by targeting network modules: a Parkinson's disease case study.NUEVO

Yue Z, Arora I, Zhang EY, Laufer V, Bridges SL, Chen JY.
BMC Bioinformatics. 2017 Dec 28;18(Suppl 14):532. doi: 10.1186/s12859-017-1889-0.
Pub MED

Response to commentary on passive smoking and Parkinson's disease in California teachers.NUEVO

Gatto NM, Deapen D, Marshall S, Bordelon Y, Bernstein L, Ritz B.
Parkinsonism Relat Disord. 2017 Dec 19. pii: S1353-8020(17)30845-3. doi: 10.1016/j.parkreldis.2017.12.019. [Epub ahead of print] No abstract available.
Pub MED

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.NUEVO

Haddad F, Sawalha M, Khawaja Y, Najjar A, Karaman R.
Molecules. 2017 Dec 25;23(1). pii: E40. doi: 10.3390/molecules23010040. Review.
Pub MED

Correction: Automatic Classification of Tremor Severity in Parkinson's Disease Using a Wearable Device. Sensors 2017, 17, 2067.NUEVO

Jeon H, Lee W, Park H, Lee HJ, Kim SK, Kim HB, Jeon B, Park KS.
Sensors (Basel). 2017 Dec 24;18(1). pii: E33. doi: 10.3390/s18010033. No abstract available.
Pub MED

Sudden unexpected death in Parkinson's disease (SUDPAR): sleep apnea increases risk of heart attack.NUEVO

Scorza FA, Tufik S, Scorza CA, Andersen ML, Cavalheiro EA.
Sleep Breath. 2017 Dec;21(4):965-966. doi: 10.1007/s11325-017-1511-8. Epub 2017 May 23. No abstract available.
Pub MED

Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease.NUEVO

Lueken U, Evens R, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Gräber-Sultan S, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O.
Int J Methods Psychiatr Res. 2017 Dec;26(4). doi: 10.1002/mpr.1564. Epub 2017 Apr 18.
Pub MED

Clinical features of Parkinson's disease with and without rapid eye movement sleep behavior disorder.NUEVO

Liu Y, Zhu XY, Zhang XJ, Kuo SH, Ondo WG, Wu YC.
Transl Neurodegener. 2017 Dec 21;6:35. doi: 10.1186/s40035-017-0105-5. eCollection 2017.
Pub MED

Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?NUEVO

Faustini G, Bono F, Valerio A, Pizzi M, Spano P, Bellucci A.
Genes (Basel). 2017 Dec 8;8(12). pii: E377. doi: 10.3390/genes8120377. Review.
Pub MED

A Possible Explanation of How High-Frequency Deep Brain Stimulation Suppresses Low-Frequency Tremors in Parkinson's Disease.NUEVO

Shah VV, Goyal S, Palanthandalam-Madapusi HJ.
IEEE Trans Neural Syst Rehabil Eng. 2017 Dec;25(12):2498-2508. doi: 10.1109/TNSRE.2017.2746623. Epub 2017 Aug 29.
Pub MED

Seasonal temperature is associated with Parkinson's disease prescriptions: an ecological study.NUEVO

Rowell D, Nghiem S, Ramagopalan S, Meier UC.
Int J Biometeorol. 2017 Dec;61(12):2205-2211. doi: 10.1007/s00484-017-1427-9. Epub 2017 Aug 30.
Pub MED

CLOCK rs1801260 Polymorphism is Associated with Susceptibility to Parkinson's Disease in a Chinese Population.NUEVO

Lou F, Li M, Ren Y, Luo XG, Liu N, Li X.
Neurosci Bull. 2017 Dec;33(6):734-736. doi: 10.1007/s12264-017-0167-5. Epub 2017 Aug 5. No abstract available.
Pub MED

Hip fractures and Parkinson's disease: A case series.NUEVO

Coomber R, Alshameeri Z, Masia AF, Mela F, Parker MJ.
Injury. 2017 Dec;48(12):2730-2735. doi: 10.1016/j.injury.2017.08.042. Epub 2017 Aug 25.
Pub MED

Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.NUEVO

Zitser J, Peretz C, Ber David A, Shabtai H, Ezra A, Kestenbaum M, Brozgol M, Rosenberg A, Herman T, Balash Y, Gadoth A, Thaler A, Stebbins GT, Goetz CG, Tilley BC, Luo ST, Liu Y, Giladi N, Gurevich T.
Parkinsonism Relat Disord. 2017 Dec;45:7-12. doi: 10.1016/j.parkreldis.2017.09.012. Epub 2017 Sep 24.
Pub MED

Closing the celebration of 200 years of Parkinson's Essay on the Shaking Palsy: Where do we go in the next 200 years?NUEVO

Goetz CG.
Mov Disord. 2017 Dec;32(12):1651-1652. doi: 10.1002/mds.27214. Epub 2017 Nov 9. No abstract available.
Pub MED

Motor complications in Parkinson's disease: Striatal molecular and electrophysiological mechanisms of dyskinesias.NUEVO

Picconi B, Hernández LF, Obeso JA, Calabresi P.
Mov Disord. 2017 Dec 8. doi: 10.1002/mds.27261. [Epub ahead of print] Review.
Pub MED

Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.NUEVO

Elson JL, Kochaj R, Reynolds R, Pienaar IS.
Neurotox Res. 2017 Dec 7. doi: 10.1007/s12640-017-9846-2. [Epub ahead of print]
Pub MED

Complication of deep brain stimulation for Parkinson's disease.NUEVO

Costa C, Gomes F, Monteiro J, Bento L.
BMJ Case Rep. 2017 Dec 6;2017. pii: bcr-2017-223264. doi: 10.1136/bcr-2017-223264. No abstract available.
Pub MED

Inventory of real world data sources in Parkinson's disease.NUEVO

Tanguy A, Jönsson L, Ishihara L.
BMC Neurol. 2017 Dec 8;17(1):213. doi: 10.1186/s12883-017-0985-0.
Pub MED

Targeted kinase inhibition relieves slowness and tremor in a Drosophila model of LRRK2 Parkinson's disease.NUEVO

Cording AC, Shiaelis N, Petridi S, Middleton CA, Wilson LG, Elliott CJH.
NPJ Parkinsons Dis. 2017 Dec 4;3:34. doi: 10.1038/s41531-017-0036-y. eCollection 2017.
Pub MED

Rab29 activation of the Parkinson's disease-associated LRRK2 kinase.NUEVO

Purlyte E, Dhekne HS, Sarhan AR, Gomez R, Lis P, Wightman M, Martinez TN, Tonelli F, Pfeffer SR, Alessi DR.
EMBO J. 2017 Dec 6. pii: e201798099. doi: 10.15252/embj.201798099. [Epub ahead of print]
Viendo del 1 al 40 de 321 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.